Invitae
In Brief This Week: Agilent Technologies; Danaher; Labcorp; Hologic; Invitae; More
News items for the week of July 22, 2024.
Top Five Articles on 360Dx Last Week: Labs Face Reimbursement Hurdles; Labcorp Buying Invitae; More
Last week, readers were most interested in a story about new payment challenges faced by clinical labs as molecular testing ramps up.
Labcorp Acquiring Invitae Assets for $239M, Posts 5 Percent Rise in Q1 Revenues
The firm's revenues for Q1 were $3.18 billion, up from $3.04 billion in the same quarter last year and above the consensus Wall Street estimate of $3.12 billion.
Invitae Q4 Estimated Revenues Rise 4 Percent
Invitae said that Q4 revenues increased approximately 14 percent year over year after adjusting for approximately $10.5 million related to discontinued businesses over the same period last year.
Top Five Articles on 360Dx Last Week: Abbott, Fujirebio Deal; Roche, PathAI Partnership; More
Last week, readers were most interested in a story about Abbott and Fujirebio partnering to develop a research-use-only test for neurofilament-light chain.
Feb 14, 2024
Invitae Files for Chapter 11 Bankruptcy Protection
Jan 31, 2024
360Dx Top 30 Slides 1 Percent in January
Jan 3, 2024
360Dx Top 30 Falls 5 Percent in 2023
Nov 8, 2023
Invitae Posts 9 Percent Q3 Revenue Decline
Oct 2, 2023
360Dx Top 30 Falls 10 Percent in September
Sep 25, 2023
Invitae Warned by NYSE of Noncompliance
Sep 1, 2023